“Anti-reflux devices containing a bidirectional, pressure-sensitive valve have the least amount of reflux”
TKO PERFORMANCE
New Anti-Reflux Evidence
Nexus TKO-6P produces the least amount of reflux compared to positive, negative, or neutral needleless connectors.
How does your needleless connector compare to TKO?
TKO DIFFERENCE
5-Years of Reduced CVAD Occlusions with TKO
Study shows a 69% CVAD occlusion reduction was sustained using TKO in place of a negative needleless connector.
TKO Resources
89% success rate with 1 IV per patient visit
Study shows occlusion improvements with TKO compared to neutral needleless connector.
Nexus TKO for Home Infusion
Treat Patients, Not Problems
The Nexus TKO 6P-HV is proven to reduce alteplase use by preventing occlusions in the first place,
so you can spend more time healing your patients instead of treating problems.
NEW RESEARCH
5 Years of Sustained Improvements with the TKO
Hartford Hospital reduced pharmacy use, medical supply waste and spending by practicing Lean occlusion management.
NEW RESEARCH
Nexus TKO 6PHV
The Home Infusion Solution
The first and only anti-reflux needleless connector for home infusion
Clinically proven to reduce occlusions, saving nursing time and reducing costs.
Nexus TKO®
Technology
Anti-reflux needleless connectors containing a bidirectional, pressure-sensitive diaphragm have the least amount of reflux during IV infusion.
2021 Infusion Therapy Standards of Practice (8th edition)
Nexus TKO PERFORMANCE
New Anti-Reflux Evidence
Nexus TKO-6P produces the least amount of reflux compared to
positive, negative, or neutral needleless connectors.
2024 INS STANDARDS
New Standard Recognizes Anti-Reflux
“Anti-reflux devices containing a bidirectional, pressure-sensitive valve
have the least amount of reflux”
TKO DIFFERENCE
5-Years of Reduced CVAD Occlusions with TKO
Study shows a 69% CVAD & PICC line occlusion reduction was sustained using TKO in place of a negative needleless connector.